Welcome to the UPF Digital Repository
Browsing by Author "Rodriguez-Vida, Alejo"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Rodriguez-Vida, Alejo"
Now showing items 1-11 of 11
-
Jiménez, Natalia; Reig, Òscar; Montalbo, Ruth; Milà-Guasch, Maria; Nadal-Dieste, Lluis; Castellano, Giancarlo; Lozano, Juan José; Victoria, Iván; Font, Albert; Rodriguez-Vida, Alejo; Carles, Joan; Suárez, Cristina; Doménech, Montserrat; Sala-González, Núria; Fernández, Pedro Luís; Rodríguez-Carunchio, Leonardo; Díaz, Sherley; Prat, Aleix; Marín-Aguilera, Mercedes; Mellado, Begoña (Frontiers, 2020)The prostatic tumor cells plasticity is involved in resistance to hormone-therapy, allowing these cells to survive despite androgen receptor inhibition. However, its role in taxanes resistance has not been fully established. ...
-
Rodriguez-Vida, Alejo; Saggese, Matilde; Hughes, Simon; Rudman, Sarah; Chowdhury, Simon; Smith, Neil R.; Lawrence, Peter; Rooney, Claire; Dougherty, Brian; Landers, Donal; Kilgour, Elaine; Arkenau, Hendrik-Tobias (BioMed Central, 2015)BACKGROUND: Urothelial cancers (UC) are the fourth most common tumours worldwide after prostate (or breast), lung and colorectal cancer. Despite recent improvements in their management, UC remain an aggressive disease ...
-
Grivas, Petros; Rodriguez-Vida, Alejo; Chowdhury, Simon (BioMed Central, 2021)Background: ATLAS evaluated the efficacy and safety of the PARP inhibitor rucaparib in patients with previously treated locally advanced/unresectable or metastatic urothelial carcinoma (UC). Methods: Patients with UC were ...
-
Bellmunt Molins, Joaquim, 1959-; Perera Bel, Júlia; Orsola, Anna; Rodriguez-Vida, Alejo; Juanpere, Nuria; Lloreta Trull, Josep, 1958-; Hernández, Silvia; Kwiatkowski, David J. (American Association for Cancer Research (AACR), 2020)High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non-muscle-invasive bladder cancer with unpredictable outcome and poorly understood risk factors. Here, we examined the association of somatic mutation ...
-
Rodriguez-Vida, Alejo; Rodríguez-Alonso, Andrés; Useros-Rodríguez, Eduardo; Lopez-Campos, Fernando; Amor-Carro, Oscar; Arribas-Ruiz, Alberto; Martínez-Torres, Javier; Roca-Pardiñas, Javier; Quesada-García, Alba; Muñoz-Del-Toro, Jacobo R.; Juárez-Soto, Álvaro (Elsevier, 2022)There was a high medical need for patients with non-metastatic castration-resistant prostate cancer (nmCRPC) when several next-generation anti-androgens (apalutamide, enzalutamide, and darolutamide) demonstrated clinically ...
-
López-Castillo, Daniel; March-Rodríguez, Alvaro; Rodriguez-Vida, Alejo; Pujol Vallverdú, Ramon Maria; Segura Tigell, Sonia (Society for Publication of Acta Dermato-Venereologica, 2020)
-
Hutson, Thomas E.; Bellmunt Molins, Joaquim, 1959-; Strijbos, Michiel H.; Rodriguez-Vida, Alejo (BMJ Publishing Group, 2017)During the last decade, the treatment of advanced or metastatic renal cell carcinoma (RCC) was revolutionised with the advent of antiangiogenic drugs and tyrosine-kinase inhibitors. Several agents targeting the vascular ...
-
Hernández Prat, Anna, 1984-; Rodriguez-Vida, Alejo; Juanpere, Nuria; Arpí Llucià, Oriol; Menéndez, Silvia; Soria-Jiménez, Luis; Martínez, Alejandro; Iarchouk, Natalia; Rojo, Federico; Albanell Mestres, Joan; Brake, Rachael; Rovira Guerín, Ana; Bellmunt Molins, Joaquim, 1959- (American Association for Cancer Research (AACR), 2019)Advanced bladder cancer is associated with a poor prognosis and limited treatment options. The PI3K/AKT/mTOR pathway is frequently activated in this disease and can be a potential therapeutic target for treatment intervention. ...
-
Rodriguez-Vida, Alejo; Strijbos, Michiel H.; Hutson, Thomas Xavier (BMJ Publishing Group, 2017)In the past decade, several agents targeting angiogenesis and signal transduction pathways have replaced the use of cytokines as standard of care treatment for metastatic renal cell carcinoma (RCC) after showing improved ...
-
Conde Estévez, David; Henríquez¸Iván; Henríquez, Iván; Muñoz-Rodríguez, Jesús; Rodriguez-Vida, Alejo (Informa Healthcare, 2022)Introduction: patients with non-metastatic castration-resistant prostate cancer (nmCRPC) are frequently poly-medicated due to age-related and androgen deprivation therapy (ADT)-derived comorbidities. In high-risk patients, ...
-
Epaillard, Nicolas; Parent, Pauline; Loriot, Yohann; Lavaud, Pernelle; Vera-Cea, E-B; Martinez-Chanza, Nieves; Rodriguez-Vida, Alejo; Dumont, Clement; Lozano, Rebeca; Llácer, Casilda; Ratta, Raffaele; Oudard, Stephane; Thibault, Constance; Auclin, Edouard (Frontiers, 2021)Introduction: Less than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no treatment guidelines are available. We aim to evaluate ...
Now showing items 1-11 of 11
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00